In vitro 3D liver tumor microenvironment models for immune cell therapy optimization
Author:
Affiliation:
1. Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology, and Research (A*STAR), Singapore, Singapore
2. Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore
Funder
National Medical Research Council
Publisher
AIP Publishing
Subject
Biomedical Engineering,Biomaterials,Biophysics,Bioengineering
Link
https://aip.scitation.org/doi/pdf/10.1063/5.0057773
Reference144 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Treatment Lines in Hepatocellular Carcinoma
3. Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
4. Sorafenib in Advanced Hepatocellular Carcinoma
5. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Functional hydrogels for hepatocellular carcinoma: therapy, imaging, and in vitro model;Journal of Nanobiotechnology;2024-07-01
2. Fluorescence‐Guided Spatial Drug Screening in 3D Colorectal Cancer Spheroids;Advanced Healthcare Materials;2024-06-03
3. Unveiling the Influence of Tumor Microenvironment and Spatial Heterogeneity on Temozolomide Resistance in Glioblastoma Using an Advanced Human In Vitro Model of the Blood‐Brain Barrier and Glioblastoma;Small;2023-08-30
4. Bioengineering of the liver;APL Bioengineering;2022-06-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3